Autoimmune lymphoproliferative syndrome other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
Line 5: Line 5:
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


== Overview ==
==Overview==
The [[histopathologic]] study may be helpful in the [[diagnosis]] of [[Autoimmune lymphoproliferative syndrome]]([[ALPS]]). Findings suggestive of [[ALPS]] include paracortical expansion due to infiltration of [[polyclonal]] [[TCR]] α/β+ [[DNT]] [[cells]], follicular [[hyperplasia]], and [[polyclonal]] [[plasmacytosis]].
The [[histopathologic]] study may be helpful in the [[diagnosis]] of [[Autoimmune lymphoproliferative syndrome]]([[ALPS]]). Findings suggestive of [[ALPS]] include paracortical expansion due to infiltration of [[polyclonal]] [[TCR]] α/β+ [[DNT]] [[cells]], follicular [[hyperplasia]], and [[polyclonal]] [[plasmacytosis]].


Line 11: Line 11:


[[Histopathological]] study findings can be helpful to [[diagnose]] [[Autoimmune lymphoproliferative syndrome]]. The findings are
[[Histopathological]] study findings can be helpful to [[diagnose]] [[Autoimmune lymphoproliferative syndrome]]. The findings are
* Paracortical expansion with infiltration of [[polyclonal]] [[TCR]] α/β+ [[DNT]] [[cells]].<ref name="LiHuang2015">{{cite journal|last1=Li|first1=Pu|last2=Huang|first2=Ping|last3=Yang|first3=Ye|last4=Hao|first4=Mu|last5=Peng|first5=Hongwei|last6=Li|first6=Fei|title=Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS)|journal=Clinical Reviews in Allergy & Immunology|volume=50|issue=1|year=2015|pages=55–63|issn=1080-0549|doi=10.1007/s12016-015-8466-y}}</ref>
 
* [[DNT]] [[cells]] express TIA-1 and CD57, CD45RO negative
*Paracortical expansion with infiltration of [[polyclonal]] [[TCR]] α/β+ [[DNT]] [[cells]].<ref name="LiHuang2015">{{cite journal|last1=Li|first1=Pu|last2=Huang|first2=Ping|last3=Yang|first3=Ye|last4=Hao|first4=Mu|last5=Peng|first5=Hongwei|last6=Li|first6=Fei|title=Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS)|journal=Clinical Reviews in Allergy & Immunology|volume=50|issue=1|year=2015|pages=55–63|issn=1080-0549|doi=10.1007/s12016-015-8466-y}}</ref>
* Follicular [[hyperplasia]]
*[[DNT]] [[cells]] express TIA-1 and CD57, CD45RO negative
* Polyclonal [[plasmacytosis]]
*Follicular [[hyperplasia]]
* [[Spleen]] has expanded [[T cell]] areas dominated by [[DNT]] [[cells]].
*Polyclonal [[plasmacytosis]]
*[[Spleen]] has expanded [[T cell]] areas dominated by [[DNT]] [[cells]].
*


==References==
==References==

Revision as of 02:19, 3 July 2021

Autoimmune lymphoproliferative syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune lymphoproliferative syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune lymphoproliferative syndrome other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune lymphoproliferative syndrome other diagnostic studies

CDC on Autoimmune lymphoproliferative syndrome other diagnostic studies

Autoimmune lymphoproliferative syndrome other diagnostic studies in the news

Blogs on Autoimmune lymphoproliferative syndrome other diagnostic studies

Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome

Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The histopathologic study may be helpful in the diagnosis of Autoimmune lymphoproliferative syndrome(ALPS). Findings suggestive of ALPS include paracortical expansion due to infiltration of polyclonal TCR α/β+ DNT cells, follicular hyperplasia, and polyclonal plasmacytosis.

Other Diagnostic Studies

Histopathological study findings can be helpful to diagnose Autoimmune lymphoproliferative syndrome. The findings are

References

  1. Li, Pu; Huang, Ping; Yang, Ye; Hao, Mu; Peng, Hongwei; Li, Fei (2015). "Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS)". Clinical Reviews in Allergy & Immunology. 50 (1): 55–63. doi:10.1007/s12016-015-8466-y. ISSN 1080-0549.

Template:WH Template:WS